today
suffici
data
avail
support
use
lactic
acid
bacteria
lab
notabl
lactococci
lactobacilli
deliveri
vehicl
develop
new
mucos
vaccin
nonpathogen
gramposit
bacteria
safe
consum
human
centuri
ferment
food
thu
constitut
attract
altern
attenu
pathogen
popular
live
vector
actual
studi
could
recov
pathogen
potenti
thu
total
safe
use
human
chapter
review
current
research
advanc
use
lab
live
deliveri
vector
protein
interest
develop
new
safe
mucos
vaccin
use
lab
dna
vaccin
vehicl
deliv
dna
directli
antigenpres
cell
immun
system
also
discuss
mucos
surfac
primari
interact
site
organ
environ
thu
repres
major
portal
entri
pathogen
last
year
sever
report
success
immunis
varieti
mucos
vector
vaccin
holmgren
czerkinski
choic
rout
immunis
govern
effici
vaccin
differ
mucosaassoci
lymphoid
tissu
malt
lymphoid
structur
associ
nasopharynx
tonsil
salivari
gland
upper
respiratori
tract
term
nasalassoci
lymphoid
tissu
nalt
bronchoepithelium
lower
respiratori
tract
balt
gastrointestin
tract
git
male
femal
genit
tract
cesta
corr
et
al
malt
cover
epithelium
contain
special
cell
known
follicleassoci
epithelium
microfold
cell
play
import
role
mainten
mucos
surfac
barrier
initi
mucos
immun
reaction
corr
et
al
cell
transport
solubl
particul
matter
across
mucos
epithelium
perform
sampl
lumin
antigen
thu
constitut
potenti
induct
site
stimul
immun
respons
furthermor
mucos
immunis
also
induc
effici
system
immun
respons
present
less
collater
side
effect
system
vaccin
final
mucos
immunis
easili
perform
without
need
needl
syring
thu
train
personnel
import
featur
mass
vaccin
program
recent
advanc
biotechnolog
understand
immun
system
render
possibl
design
new
mucos
deliveri
system
vehicl
includ
inert
system
purifi
antigen
nake
dna
associ
microspher
liposom
nanoparticul
immunostimul
complex
well
live
bacteri
viral
vector
system
christensen
et
al
daudel
et
al
hu
et
al
illum
davi
jen
bachmann
mielcarek
et
al
singh
et
al
live
bacteria
virus
immunogen
inert
vector
thu
repres
better
candid
induc
mucos
system
immun
respons
infecti
agent
vaccinia
viru
deriv
frequent
use
viru
vaccin
moss
ulaeto
hrubi
howev
last
year
vector
progress
replac
poxvirus
canari
fowl
pox
virus
adenovirus
beukema
et
al
karkhani
ross
patterson
robertguroff
live
bacteri
vector
either
base
attenu
pathogen
nonpathogen
bacteria
daudel
et
al
well
merceni
tabl
compar
virus
genom
limit
capac
encapsul
sever
foreign
dna
genom
live
bacteri
vector
harbor
mani
heterolog
gene
recombin
bacteria
thu
produc
mani
differ
heterolog
antigen
may
allow
develop
multival
vaccin
immunogen
solubl
protein
oral
intranas
administ
low
significantli
enhanc
either
coupl
protein
bacteri
carrier
genet
engin
bacteria
result
product
desir
antigen
attenu
pathogen
bacteria
deriv
mycobacterium
salmonella
bordetella
spp
particularli
well
adapt
interact
mucos
surfac
use
initi
infect
process
unfortun
organ
could
recov
pathogen
potenti
total
safe
use
human
especi
children
immunosuppress
patient
alexandersen
gramposit
foodgrad
commens
bacteria
belong
commens
flora
human
malt
constitut
attract
altern
attenu
pathogen
bacteria
well
merceni
particular
foodgrad
lactic
acid
bacteria
lab
lactococcu
lacti
certain
speci
lactobacilli
possess
number
properti
make
attract
candid
develop
mucos
vaccin
et
al
inde
lab
use
centuri
ferment
preserv
food
consid
safe
organ
gra
gener
recogn
safe
statu
moreov
sever
antigen
andor
cytokin
success
express
lab
mucos
et
al
develop
mucos
vaccin
base
lactic
acid
bacteria
administr
genet
engin
lab
shown
elicit
system
mucos
immun
tabl
product
desir
antigen
lab
theori
occur
three
differ
cellular
locat
intracellular
locat
allow
protein
escap
drastic
environment
condit
gastric
juic
stomach
oral
administr
recombin
strain
requir
cellular
lysi
protein
deliveri
extracellular
locat
allow
releas
protein
extern
medium
thu
direct
interact
environ
food
product
digest
tract
cell
surfaceattach
cellular
locat
combin
advantag
first
one
ie
interact
cell
wallanchor
protein
environ
protect
proteolysi
degrad
context
sever
studi
compar
product
differ
antigen
lab
use
three
localis
evalu
subsequ
immunolog
effect
review
et
al
well
merceni
studi
shown
highest
immun
respons
obtain
antigen
expos
surfac
lab
therefor
recent
studi
select
surfac
exposur
antigen
interest
rather
intraor
extracellular
product
lactococcu
lacti
live
vaccin
deliveri
vector
lactococcu
lacti
wide
use
lab
product
ferment
milk
product
consid
model
lab
mani
genet
tool
develop
complet
genom
sequenc
bolotin
et
al
lo
lacti
consid
good
candid
heterolog
protein
product
secret
rel
protein
van
asseldonk
et
al
addit
commonli
use
laboratori
strain
l
lacti
plasmidfre
produc
extracellular
proteas
gasson
howev
major
advantag
use
l
lacti
live
vector
mucos
deliveri
therapeut
protein
resid
extraordinari
safeti
profil
sinc
bacterium
catalogu
noninvas
nonpathogen
organ
gra
statu
final
capac
l
lacti
produc
antigen
clearli
demonstr
last
decad
tabl
featur
make
l
lacti
potenti
candid
develop
new
safe
mucos
vaccin
first
attempt
analyz
potenti
l
lacti
mucos
vaccin
perform
kill
recombin
lactococci
produc
cell
wallattach
form
streptococcu
mutan
protect
antigen
pac
mice
immun
oral
recombin
strain
develop
pacspecif
serum
igg
mucos
iga
antibodi
iwaki
et
al
result
show
first
time
l
lacti
use
deliveri
vector
present
antigen
immun
system
howev
well
et
al
report
first
time
use
live
recombin
l
lacti
produc
tetanu
fragment
c
ttfc
protect
mice
via
subcutan
inject
lethal
challeng
tetanu
toxin
later
group
evalu
effect
oral
intranas
administr
live
recombin
lactococci
produc
ttfc
mice
norton
et
al
robinson
et
al
oral
immun
mice
result
lower
serum
igg
mucos
iga
antibodi
respons
nasal
immun
wherea
protect
efficaci
ie
challeng
tetanu
toxin
sever
studi
conduct
analyz
express
mani
viral
bacteri
eukaryot
heterolog
protein
l
lacti
et
al
tabl
immunogen
result
recombin
strain
evalu
case
mous
model
promis
result
among
one
best
document
project
base
use
recombin
l
lacti
produc
human
papillomaviru
antigen
viral
protein
consid
major
candid
antigen
vaccin
hpvrelat
cervic
cancer
second
caus
cancer
death
women
intracellular
product
antigen
model
led
rapid
degrad
cytoplasm
l
lacti
even
produc
proteasefre
strain
et
al
contrast
secret
cell
wallanchor
form
rescu
proteolysi
produc
higher
level
l
lacti
dez
et
al
et
al
antigenspecif
humor
product
antibodi
cellular
secret
ifng
cytokin
respons
observ
intranas
administr
mice
recombin
lactococci
express
antigen
differ
level
cellular
locat
significantli
higher
mice
immun
l
lacti
express
cell
wallanchor
form
et
al
first
report
product
foodgrad
lab
repres
one
step
toward
develop
therapi
hpvrelat
cervic
cancer
inde
protect
effect
mucos
coadminist
live
l
lacti
strain
express
cell
wallanchor
secret
form
treat
tumor
murin
model
evalu
et
al
challeng
lethal
level
tumor
cell
line
express
pretreat
mice
show
full
prevent
tumor
therapeut
immun
recombin
strain
ie
day
inject
induc
regress
palpabl
tumor
treat
mice
preclin
result
suggest
feasibl
mucos
vaccin
andor
immunotherapi
hpvrelat
cervic
cancer
use
genet
engin
lactococci
although
immunolog
studi
perform
l
lacti
produc
ttfc
antigen
report
support
recombin
lactococci
mucos
vaccin
continu
grow
today
approxim
peerreview
public
valid
potenti
tabl
contrast
lactococci
lactobacilli
speci
persist
longer
git
sometim
colon
certain
region
mucosa
induc
local
immun
respons
second
benefit
use
lactobacilli
strain
consid
probiot
ie
show
healthpromot
activ
human
anim
seeger
inde
genu
widespread
contain
speci
differ
biochem
ecolog
immunolog
properti
biodivers
develop
mucos
vaccin
base
lactic
acid
bacteria
render
use
lactobacillu
spp
vaccin
vehicl
complex
compar
l
lacti
one
singl
strain
use
howev
capac
genu
lactobacillu
produc
antigen
also
demonstr
immun
respons
antigen
deliv
lactobacillu
spp
use
genet
modifi
lactobacilli
ie
l
fermentum
l
acidophilu
l
casei
l
plantarum
produc
heterolog
protein
develop
new
gener
mucos
vaccin
first
propos
decad
pouwel
et
al
rush
et
al
end
earli
sever
laboratori
use
recombin
strain
lb
casei
lb
plantarum
vehicl
medic
protein
deliveri
mucos
surfac
stimul
strong
local
immun
respons
review
seeger
well
merceni
approxim
peerreview
public
publish
confirm
advantag
genu
lactobacillu
live
mucos
vaccin
l
lacti
sever
studi
also
conduct
analyz
express
varieti
viral
bacteri
eukaryot
origin
lb
plantarum
lb
casei
tabl
immunogen
recombin
lb
plantarum
produc
antigen
evalu
mous
model
promis
result
cort
perez
et
al
recombin
lactic
acid
bacteria
dna
deliveri
vehicl
contrast
bacteriamedi
deliveri
protein
antigen
bacteriamedi
deliveri
dna
vaccin
lead
express
posttransl
modifi
antigen
host
cell
therefor
present
conform
restrict
epitop
fout
et
al
protein
deliveri
use
foodgrad
lab
dna
deliveri
vehicl
promis
altern
attenu
pathogen
dna
vaccin
carrier
l
lacti
strain
use
deliv
express
cassett
encod
bovin
blactoglobulin
blg
cdna
one
major
cow
milk
allergen
transcript
control
viral
promot
cmv
epitheli
cell
line
express
cassett
insert
one
l
lacti
replic
plasmid
product
secret
blg
observ
cell
incub
l
lacti
carri
express
plasmid
demonstr
non
invas
l
lacti
abl
deliv
fulli
function
plasmid
epitheli
cell
interestingli
product
blg
observ
cell
coincub
purifi
plasmid
alon
mix
l
lacti
suggest
plasmid
insid
bacterium
achiev
transfer
subsequ
blg
product
epitheli
cell
et
al
oral
administr
l
lacti
carri
eukaryot
express
cassett
encod
blg
blg
cdna
protein
detect
small
intestin
h
last
administr
blg
detect
day
last
oral
administr
mice
develop
blg
specif
primari
immun
respons
character
weak
transitori
respons
serum
sensit
pretreat
mice
ige
concentr
decreas
respect
compar
sensit
naiv
mice
moreov
splenocyt
pretreat
mice
secret
ifng
blg
specif
reactiv
chatel
et
al
mice
effect
protect
sensit
specif
respons
immun
respons
l
acidophilu
carri
dna
vaccin
antigen
foodandmouthdiseas
viru
fmdv
investig
administr
system
mucos
rout
rout
administr
signific
impact
magnitud
system
immur
respons
inde
strong
immun
respons
vaccin
antigen
detect
inject
rout
administr
although
mucos
administr
could
prime
specif
immun
respons
intramuscular
administr
gener
highest
level
fmdv
antibodi
follow
intraperiton
intranas
oral
rout
recombin
invas
lactic
acid
bacteria
dna
deliveri
vehicl
demonstr
recombin
e
coli
invas
host
cell
limit
step
achiev
effici
dna
vaccin
deliveri
grillotcourvalin
et
al
increas
lab
dna
vaccin
deliveri
effici
l
lacti
modifi
order
becom
invas
express
inla
gene
listeria
monocytogen
inla
gene
code
internalin
surfac
protein
mediat
invas
non
phagocyt
cell
listeria
monocytogen
gaillard
et
al
mengaud
et
al
inla
bind
extracellular
domain
ecadherin
develop
mucos
vaccin
base
lactic
acid
bacteria
transmembran
celltocel
adhes
molecul
mengaud
et
al
inla
necessari
invas
epitheli
cell
suffici
reconstitut
invas
express
nonpathogen
noninvas
speci
listeria
innocua
mengaud
et
al
moreov
inla
express
l
lacti
promot
intern
lactococci
human
epitheli
line
vitro
enterocyt
vivo
oral
administr
guinea
pig
addit
l
lacti
inla
abl
deliv
function
plasmid
code
gfp
cell
express
gfp
cocultur
strain
et
al
methodolog
techniqu
genet
manipul
lactic
acid
bacteria
genet
engin
lab
produc
heterolog
protein
express
system
use
base
constitut
induc
promot
import
featur
must
consid
vivo
deliveri
live
bacteri
vector
high
product
level
heterolog
protein
l
lacti
achiev
use
constitut
promot
howev
continu
highlevel
product
certain
protein
cytokin
observ
could
lead
intracellular
accumul
degrad
could
deleteri
cell
therebi
prevent
possibl
neg
effect
caus
high
product
induc
promot
develop
system
gene
express
control
inductor
repressor
environment
factor
ph
temperatur
ion
concentr
morello
et
al
today
one
best
character
express
system
nice
nisincontrol
express
system
mierau
kleerebezem
nice
system
allow
control
gene
express
addit
nisin
antimicrobi
peptid
use
natur
preserv
food
industri
versatil
system
level
gene
express
control
amount
nisin
use
induct
upregul
mierau
kleerebezem
l
lacti
noncolon
bacterium
therefor
system
allow
preload
organ
antigen
vivo
applic
highli
desir
induct
nice
system
consid
good
strategi
obtain
high
level
heterolog
antigen
product
vitro
addit
even
vitro
nisinpuls
recombin
l
lacti
continu
produc
heterolog
protein
evok
antigenspecif
respons
administ
mice
et
al
observ
support
use
nice
system
express
heterolog
protein
l
lacti
sever
deliveri
system
develop
target
heterolog
protein
differ
level
cellular
locat
within
l
lacti
et
al
well
merceni
well
et
al
context
famili
new
vector
allow
heterolog
antigen
express
l
lacti
either
intracellularli
extracellularli
cell
wallattach
design
et
al
cortesperez
et
al
small
vector
base
broadhostrang
pgk
plasmid
kok
et
al
compos
cassett
allow
easi
exchang
differ
express
signal
andor
gene
moreov
vector
capac
replic
gramposit
bacteria
includ
bacillu
subtili
l
lacti
lactobacillu
spp
escherichia
coli
procedur
dna
clone
sometim
labori
gramposit
organ
perform
e
coli
recombin
vector
establish
bacterium
transfer
desir
gramposit
bacterium
importantli
vector
use
produc
success
differ
heterolog
antigen
l
lacti
tabl
well
illustr
exampl
effici
system
produc
heterolog
antigen
express
antigen
human
papillomaviru
initi
dna
plasmid
construct
perform
e
coli
express
differ
level
cellular
locat
use
famili
vector
describ
ie
pcyt
psec
pcwa
confirm
sequenc
recombin
vector
transfer
success
l
lacti
product
evalu
western
blot
analysi
follow
protocol
prepar
electrocompet
cell
l
lacti
cfumg
dna
approxim
recommend
strain
grown
overnight
ml
medium
difco
supplement
glucos
sucros
glycin
c
without
agit
cultur
inocul
ml
medium
incub
c
optic
densiti
reach
cultur
incub
immedi
ice
min
stir
everi
min
cell
pellet
centrifug
rpm
min
c
cellular
pellet
wash
twice
develop
mucos
vaccin
base
lactic
acid
bacteria
ml
wash
buffer
sucros
glycerol
third
wash
perform
ml
buffer
final
pellet
resuspend
ml
peggli
polyethyleneglycol
glycerol
aliquot
ml
made
ml
microcentrifug
tube
frozen
immedi
liquid
nitrogen
store
c
use
transform
ml
electrocompet
cell
mix
ml
dna
ml
case
ligat
transfer
chill
electropor
cuve
mm
expos
singl
electr
puls
genepuls
biorad
laboratori
mf
kv
immedi
electr
discharg
ml
medium
sucros
ad
incub
h
plasmid
express
final
differ
dilut
plate
agar
plu
antibiot
marker
recombin
coloni
select
h
incub
c
lactobacillu
spp
adapt
protocol
use
l
lacti
briefli
overnight
cultur
strain
lactobacillu
test
success
three
differ
lactobacillu
speci
grown
mr
medium
difco
supplement
glycin
mrsg
c
without
agit
cultur
inocul
ml
medium
cultur
continu
c
cultur
incub
immedi
ice
min
stir
everi
min
pellet
cell
centrifug
rpm
min
c
pellet
wash
volum
mm
cold
magnesium
chlorid
volum
cold
polyethylen
glycol
glycerol
peggli
final
pellet
suspend
initi
volum
peggli
aliquot
ml
immedi
frozen
liquid
nitrogen
store
c
use
optim
condit
electrotransform
singl
electr
puls
genepuls
biorad
laboratori
mf
kv
chill
electropor
cuve
mm
immedi
electr
shock
ml
mrssm
medium
mr
plu
mm
sucros
mm
ad
incub
h
plasmid
express
final
differ
dilut
plate
mr
agar
plu
antibiot
recombin
clone
select
h
incub
c
express
desir
antigen
l
lacti
use
nice
system
recommend
follow
heterolog
protein
express
perform
use
either
ngml
nisin
sigma
period
previous
describ
et
al
protein
sampl
prepar
ml
induc
cultur
cell
pellet
supernat
treat
separ
inhibit
proteolysi
supernat
sampl
mm
phenylmethylsulfonyl
fluorid
mm
dithiothreitol
ad
protein
precipit
addit
ml
trichloroacet
acid
incub
min
ice
centrifug
min
rpm
c
cell
fraction
tesli
buffer
sucros
mm
edta
mm
trishcl
ph
lysozym
mgml
complement
mm
phenylmethylsulfonyl
fluorid
mm
dithiothreitol
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
western
blot
immunorevel
antibodi
perform
lactobacilli
induct
essenti
perform
follow
overnight
cultur
dilut
h
growth
nisin
ad
ngml
cultur
continu
h
protein
extract
immunoblot
assay
antibodi
perform
previous
describ
corrobor
protein
surfac
express
lactococci
lactobacilli
recombin
strain
grown
induc
describ
analys
immunofluoresc
microscopi
ifm
end
induct
phase
ml
cultur
harvest
suspend
ml
steril
pbsbsa
bovin
serum
albumin
contain
correspond
antibodi
incub
overnight
room
temperatur
three
wash
pbst
pbstween
cellantibodi
complex
incub
h
room
temperatur
avoid
light
exposur
solut
dilut
pbsbsa
goatderiv
antimous
immunoglobulin
g
igg
h
l
conjug
alexa
fluor
dye
molecular
probe
europ
bv
cell
wash
three
time
pbstand
pellet
suspend
ml
pb
final
afterward
differ
dilut
perform
determin
optim
quantiti
obtain
clear
field
microscopi
usual
ml
dilut
visual
entir
cell
popul
bacteria
stain
dapi
mgml
sigma
laid
glass
slide
air
dri
heat
fix
pictur
cell
taken
ifm
equip
three
band
filter
set
emiss
light
nikon
tokyo
japan
sensia
film
fuji
tokyo
japan
filter
appropri
red
excit
light
use
visual
cell
develop
mucos
vaccin
base
lactic
acid
bacteria
stain
alexa
fluor
fluorophor
addit
bacteri
imag
taken
without
filter
excit
light
allow
cell
stain
dapi
alexa
fluor
compar
simultan
hybrid
cell
count
imag
captur
imag
analysi
system
visiolab
biocom
le
uli
franc
bacteri
cultur
induc
describ
cell
pellet
harvest
wash
three
time
steril
pb
pellet
suspend
ml
pb
obtain
final
concentr
colonyform
unit
cfu
three
mice
week
immun
intranas
cfu
induc
recombin
lab
strain
ml
administ
micropipett
nostril
day
mice
partial
anesthet
intraperiton
inject
combin
xylazin
ketamin
ml
kg
weight
plate
count
perform
check
amount
cfu
administ
control
mice
receiv
ident
quantiti
wildtyp
lab
strain
bacteri
entri
human
epitheli
cell
assay
use
human
colon
carcinoma
cell
line
atcc
number
describ
dramsi
et
al
eukaryot
cell
cultur
rpmi
supplement
mm
lglutamin
biowhittak
cambrex
bio
scienc
vervier
belgium
fetal
calf
serum
fc
gentamicin
surviv
assay
use
estim
bacteria
surviv
l
lacti
strain
grown
od
wash
pb
dilut
multipl
infect
moi
bacteria
per
cell
bacteri
suspens
ad
mammalian
cell
grown
plate
corn
glass
work
cell
seed
well
day
experi
h
contact
intern
gentamicin
mgl
ad
cultur
medium
h
incub
cell
wash
lyze
serial
dilut
lysat
plate
bacteri
count
gentamicin
invas
assay
done
triplic
develop
mucos
vaccin
base
lactic
acid
bacteria
conclus
therapeut
applic
lab
progress
rapidli
last
year
follow
demonstr
lab
ie
l
lacti
could
treat
coliti
mous
model
steidler
et
al
success
phase
clinic
trial
recent
conduct
patient
crohn
diseas
braat
et
al
howev
approv
clinic
studi
develop
contain
system
genet
modifi
l
lacti
necessari
address
safeti
concern
use
l
lacti
human
chromosom
thymidyl
synthas
thya
gene
replac
gene
encod
gener
thymin
auxotroph
phenotyp
viabil
thya
strain
reduc
sever
order
magnitud
absenc
thymidin
thymin
contain
valid
vivo
pig
steidler
et
al
strikingli
phase
clinic
trial
conduct
thya
strain
patient
crohn
diseas
show
contain
strategi
effect
braat
et
al
studi
open
new
door
use
recombin
lab
deliveri
vehicl
futur
excit
applic
horizon
concern
deliveri
dna
vaccin
use
lab
chatel
et
al
allergenspecif
immunotherapi
allerg
diseas
huibregts
et
al
antiinfect
molecul
scfv
antibodi
microbiocid
chang
et
al
chancey
et
al
et
al
liu
et
al
possibl
express
factor
scfv
antibodi
host
target
molecul
immunomodul
lab
hope
see
applic
progress
toward
studi
human
lactococcu
lacti
secret
murin
inter
